Compare OMER & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMER | CYD |
|---|---|---|
| Founded | 1994 | 1951 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2008 | 1998 |
| Metric | OMER | CYD |
|---|---|---|
| Price | $13.29 | $19.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $27.50 | ★ $47.94 |
| AVG Volume (30 Days) | ★ 1.2M | 149.2K |
| Earning Date | 11-16-2026 | 08-07-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | ★ 98.15 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $29,868,000.00 | N/A |
| Revenue This Year | N/A | $13.32 |
| Revenue Next Year | $66.13 | $8.59 |
| P/E Ratio | $107.77 | ★ $32.71 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.70 | $19.74 |
| 52 Week High | $21.24 | $61.48 |
| Indicator | OMER | CYD |
|---|---|---|
| Relative Strength Index (RSI) | 30.78 | 30.47 |
| Support Level | $9.45 | $19.74 |
| Resistance Level | $19.68 | $35.66 |
| Average True Range (ATR) | 0.92 | 1.09 |
| MACD | -0.45 | 0.34 |
| Stochastic Oscillator | 8.90 | 2.59 |
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.